Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.107 (
DAT
)
1,471
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Although visuoconstructive impairment has been reported in both Alzheimer's (
DAT
) and Huntington's (HD) disease, there is little knowledge concerning how this cognitive deficit differs quantitatively and qualitatively in these two progressive dementias. To address this issue, the present study compared performances on the Clock Drawing Test (
CDT
: command and copy) of 25
DAT
patients, 25 equally demented HD patients, and 25 elderly normal controls (NC). In the command condition, both patients groups were significantly impaired compared to the NC group. Although there was no significant difference between
DAT
and HD patients' total quantitative scores, a qualitative error analysis revealed a number of dissociations between the two patient groups. Graphic difficulties, very common in HD patients, were virtually absent in
DAT
patients; in contrast, conceptual errors were almost exclusively seen in
DAT
patients and were related to the severity of their dementia. Perseveration and "stimulus-bound" responses were also more frequent in
DAT
patients, and both groups made visuospatial errors. In the copy condition, the
DAT
, but not the HD, patients evidenced a marked improvement in performance. These results indicate that while both
DAT
and HD patients have significant visuoconstructive difficulties even in the early stages of their disorders, the specific cognitive processes underlying their quantitative impairments are quite different. It is possible that the
DAT
patients' conceptual errors are yet another indicator of the deterioration of their semantic knowledge.
...
PMID:Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease. 154 77